Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna E. Krug
Observed names:
Anna E Krug,
Anna Krug
Institution:
University of Colorado Anschutz
Observed institutions:
University of Iowa,
University of Iowa Health Care,
University of Iowa Holden Comprehensive Cancer Center,
University of Colorado Anschutz,
University of Colorado Denver
ORCID:
0009-0005-2961-3999
Observed ORCID:
0009-0005-2961-3999
OpenAlex ID:
A5020965297
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2023
·
Shanshan Pei
, Ian T. Shelton
, et al.
·
Cancer Discovery
·
123
PDF
Antibody Opsonization of a TLR9 Agonist–Containing Virus-like Particle Enhances In Situ Immunization
2020
·
Caitlin D Lemke-Miltner
, Sue E Blackwell
, et al.
·
The Journal of Immunology
·
64
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024
·
Anagha Inguva Sheth
, Krysta Engel
, et al.
·
Cancer Discovery
·
62
PDF
The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
·
Blood Cancer Discovery
·
2
PDF
Table S6 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S1 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S11 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S3 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S13 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S9 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S10 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S4 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S2 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S14 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S4 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S8 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S2 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S1 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S3 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Data from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S7 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S5 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S12 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S5 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Supplementary Table 2 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025
·
Shanshan Pei
, Ian T. Shelton
, et al.
Show more works
View as search
Works count:
62
Citation count:
251
H-index:
3
I10-index:
3
Year
Topic
Type